Europe TIC Market for Pharmaceuticals and Biotech Industry Size, Share, Growth and Demand by 2030

2025

2030

Europe TIC Market for Pharmaceuticals and Biotech Industry Size & Share | Growth Forecast Report 2030

Industry Insight by Sourcing Type (In-House and Outsourced), by Service Type (Testing, Inspection, and Certification), by Industry Vertical (Extractable and Leachable Studies, Environmental Monitoring, Biopharmaceutical and Biologics Analysis, Sterile Compounding, Pharmaceutical Method Development and Research, pharmaceutical X-ray Diffraction, Excipient Raw Materials and Container Testing, Material Sciences Testing, Disinfection Qualification, Trace Metal Services, and Others), and by Geography (Europe)

Ask for Customization

Request for Sample

Industry Overview

The Europe TIC Market for Pharmaceuticals and Biotech Industry reached USD 8.6 billion in 2030, currently, in year 2023 the market is USD 3.4 billion with a projected CAGR of 3.4% from 2025 to 2030.

The pharmaceutical and biotech sectors' European Testing, Inspection, and Certification (TIC) market is expanding significantly due to stricter laws, rising healthcare product safety and quality demands, and supply chain globalization. The growing use of outsourced TIC services for transparency, the use of automation and artificial intelligence (AI) to improve efficiency, and the requirement for specific certifications for cutting-edge medical devices are some of the major trends.

Europe TIC Market for Pharmaceuticals and Biotech Industry Trends/ Growth Drivers:

Predictive analytics and automated report creation are two examples of how artificial intelligence (AI) and automation are being used to improve the effectiveness and precision of testing and inspection procedures. The need for specialized certification services is being driven by the growing complexity and innovation in medical devices, especially implantable devices and in-vitro diagnostics. The medical devices segment is a significant area within the broader healthcare TIC market, with strong growth driven by strict regulations and the need to ensure safety. In order to guarantee product safety and effectiveness, the EU's broad regulatory framework for pharmaceuticals and medical devices requires extensive testing and certification, leading to greater demand for TIC services. Also, to uphold high standards, businesses are investing in independent TIC services as a result of consumers' and healthcare professionals' increased awareness of the safety and quality of medical products. Due to the quick acceptance of new technologies in biotech and pharmaceuticals, such as personalized medication and sophisticated devices for diagnosis are playing an important role.

Europe TIC Market for Pharmaceuticals and Biotech Industry Report Coverage

Report Metric	Details
Historical Period	2018 - 2023
Base Year Considered	2024
Forecast Period	2025 - 2030
Market Size in 2024	U.S.D. 3.4 Billion
Revenue Forecast in 2030	U.S.D. 8.6 Billion
Growth Rate	3.4%
Segments Covered in the Report	By Sourcing Type, By Service Type and By Industry Vertical
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	Europe

Europe TIC Market for Pharmaceuticals and Biotech Industry Challenges:

Despite its goal of unity, the EU offers a diverse environment with distinct local review, reimbursement, and regulatory procedures in each member state, making it more difficult for medications and diagnostic combinations to consistently enter the market. New compliance issues are brought about by the increased requirement for data privacy and strong cybersecurity safeguards as a result of the growing reliance on big data and digital technologies for testing and inspection.

Europe TIC Market for Pharmaceuticals and Biotech Industry Opportunities:

Strict regulatory compliance, patient safety requirements, and the trend toward outsourcing testing services are the main drivers of opportunities in the European TIC (Testing, Inspection, and Certification) industry for biotech and pharmaceuticals. Material sciences for drug delivery systems, environmental and microbiological testing, extractable and leachable research, and clinical trial support are some of the specific growth areas. Businesses may also be able to offer services in the areas of sterile compounding testing, pharmaceutical technique development, and biologics analysis.

Recent Developments by Key Players

ALS acquired Eurofins Pharma’s Pharmaceutical Testing Services division, which bolstered ALS’s capabilities in bioanalytical testing and clinical trial services.

Europe TIC Market for Pharmaceuticals and Biotech Industry Segmentation

VynZ Research provides an analysis of the key trends in each segment of Europe TIC Market for Pharmaceuticals and Biotech Industry report, along with forecasts at the regional and country levels from 2025-2030. Our report has categorized the market based on sourcing type, service type, and industry vertical.

Insight by Sourcing Type

In-House
Outsourced

The European TIC market for the pharmaceutical and biotech industry is divided into two segments based on the kind of sourcing that is in-house and outsourced. The highest share is in-house since it gives firms control over their technological, laboratory, skilled, and testing and measurement equipment processes through in-house testing, inspection, and certification.

Insight by Service Type

Testing
Inspection
Certification

The European TIC market for the pharmaceutical and biotech industry is divided into three segments based on the type of services provided testing, inspection, and certification. Among these verticals, testing dominates the TIC market in the pharmaceutical and biotech industry due to diverse standards, mandatory regulations, rising adoption for improved safety, industrialization, and a need to provide credibility. Testing in the pharmaceutical industry should be on quality assurance, ingredient validation, and label reviews, microbiological testing benchmarking analysis.

Insight by Industry Vertical

Extractable and Leachable Studies
Environmental Monitoring
Biopharmaceutical and Biologics Analysis
Sterile Compounding
Pharmaceutical Method Development and Research
pharmaceutical X-ray Diffraction
Excipient Raw Materials and Container Testing
Material Sciences Testing
Disinfection Qualification
Trace Metal Services
Others

Extractable and Leachable Studies, Environmental Monitoring, Biopharmaceutical and Biologics Analysis, Sterile Compounding, Pharmaceutical Method Development and Research, pharmaceutical X-ray Diffraction, Excipient Raw Materials and Container Testing, Material Sciences Testing, Disinfection Qualification, Trace Metal Services, and Others are the industry verticals that make up the Europe pharmaceutical and biotech TIC market. Examining the effects of extractable and leachable compounds on drug product interactions and safety is crucial for patient protection and legal compliance. Sterile drugs that need to be used include injectable, compounded, intravenous, and intraocular drugs which keeps pharmacists from utilizing commercially available formulations allowing them to prescribe specific medications to individuals with specific allergies or dose requirements.

Europe TIC Market for Pharmaceuticals and Biotech Industry Geographic Overview

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Germany dominates the Europe TIC market for Pharmaceuticals and Biotech Industry as it is a home to some of the world's leading pharmaceutical companies and regulatory bodies.

Europe TIC Market for Pharmaceuticals and Biotech Industry Competitive Insight:

The Europe TIC Market for Pharmaceuticals and Biotech Industry report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

1. Research Overview

1.1. The Report Offers
1.2. Market Coverage
1.2.1. By Sourcing Type
1.2.2. By Service Type
1.2.3. By Industry Vertical
1.3. Research Phases
1.4. Limitations
1.5. Market Methodology
1.5.1. Data Sources
1.5.1.1. Primary Research
1.5.1.2. Secondary Research
1.5.2. Methodology
1.5.2.1. Data Exploration
1.5.2.2. Forecast Parameters
1.5.2.3. Data Validation
1.5.2.4. Assumptions
1.5.3. Study Period & Data Reporting Unit

2. Executive Summary

3. Industry Overview

3.1. Industry Dynamics
   3.1.1. Market Growth Drivers
   3.1.2. Market Restraints
   3.1.3. Key Market Trends
   3.1.4. Major Opportunities
3.2. Industry Ecosystem
   3.2.1. Porter’s Five Forces Analysis
   3.2.2. Recent Development Analysis
   3.2.3. Value Chain Analysis
3.3. Competitive Insight
   3.3.1. Competitive Position of Industry Players
   3.3.2. Market Attractive Analysis
   3.3.3. Market Share Analysis

4. Global Market Estimate and Forecast

4.1. Global Market Overview
4.2. Global Market Estimate and Forecast to 2030

5. Market Segmentation Estimate and Forecast

5.1. By Sourcing Type
   5.1.1. In-House
   5.1.1.1. Market Definition
   5.1.1.2. Market Estimation and Forecast to 2030
   5.1.2. Outsourced
   5.1.2.1. Market Definition
   5.1.2.2. Market Estimation and Forecast to 2030

5.2. By Service Type
   5.2.1. Testing
   5.2.1.1. Market Definition
   5.2.1.2. Market Estimation and Forecast to 2030
   5.2.2. Inspection
   5.2.2.1. Market Definition
   5.2.2.2. Market Estimation and Forecast to 2030
   5.2.3. Certification
   5.2.3.1. Market Definition
   5.2.3.2. Market Estimation and Forecast to 2030

5.3. By Industry Vertical
   5.3.1. Extractable and Leachable Studies
   5.3.1.1. Market Definition
   5.3.1.2. Market Estimation and Forecast to 2030
   5.3.2. Environmental Monitoring
   5.3.2.1. Market Definition
   5.3.2.2. Market Estimation and Forecast to 2030
   5.3.3. Biopharmaceutical and Biologics Analysis
   5.3.3.1. Market Definition
   5.3.3.2. Market Estimation and Forecast to 2030
   5.3.4. Sterile Compounding
   5.3.4.1. Market Definition
   5.3.4.2. Market Estimation and Forecast to 2030
   5.3.5. Pharmaceutical Method Development and Research
   5.3.5.1. Market Definition
   5.3.5.2. Market Estimation and Forecast to 2030
   5.3.6. pharmaceutical X-ray Diffraction
   5.3.6.1. Market Definition
   5.3.6.2. Market Estimation and Forecast to 2030
   5.3.7. Excipient Raw Materials and Container Testing
   5.3.7.1. Market Definition
   5.3.7.2. Market Estimation and Forecast to 2030
   5.3.8. Material Sciences Testing
   5.3.8.1. Market Definition
   5.3.8.2. Market Estimation and Forecast to 2030
   5.3.9. Disinfection Qualification
   5.3.9.1. Market Definition
   5.3.9.2. Market Estimation and Forecast to 2030
   5.3.10. Trace Metal Services
   5.3.10.1. Market Definition
   5.3.10.2. Market Estimation and Forecast to 2030
   5.3.11. Others
   5.3.11.1. Market Definition
   5.3.11.2. Market Estimation and Forecast to 2030

6. Germany Market Estimate and Forecast

6.1. By Sourcing Type
6.2. By Service Type
6.3. By Industry Vertical

7. U.K. Market Estimate and Forecast

7.1. By Sourcing Type
7.2. By Service Type
7.3. By Industry Vertical

8. France Market Estimate and Forecast

8.1. By Sourcing Type
8.2. By Service Type
8.3. By Industry Vertical

9. Italy Market Estimate and Forecast

9.1. By Sourcing Type
9.2. By Service Type
9.3. By Industry Vertical

10. Spain Market Estimate and Forecast

10.1. By Sourcing Type
10.2. By Service Type
10.3. By Industry Vertical

11. Russia Market Estimate and Forecast

11.1. By Sourcing Type
11.2. By Service Type
11.3. By Industry Vertical

12. Rest of Europe Market Estimate and Forecast

12.1. By Sourcing Type
12.2. By Service Type
12.3. By Industry Vertical

10. Company Profiles

   10.1. Intertek Group plc
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
   10.1. Bureau Veritas
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
   10.1. UL LLC
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
   10.1. SGS SA
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
   10.1. Eurofins Scientific
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
   10.1. The British Standards Institution
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
   10.1. ALS Limited
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
   10.1. DEKRA SE
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
   10.1. Applus+
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
   10.1. TUV SUD.
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments

11. Appendix

11.1. Exchange Rates
11.2. Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.

Purchase Options

Enquire Before Buying

Ask for Customization

Latest Report

Research Methodology

Desk Research / Pilot Interviews
Build Market Size Model
Research and Analysis
Final Deliverabvle

Connect With Our Sales Team